US Patent Number
6653319
Publication Date
11-25-2003
Abstract
The present invention provides a general method to retard the precipitation inception time for poorly water-soluble camptothecin analogues from a supersaturated solution by a chemical conversion approach via pH alteration. This method is successfully utilized to prepare stable parenteral formulations for silatecan 7-t-butyldimethylsilyl-10-hydroxycamptothecin (DB-67), a poorly water-soluble lipophilic camptothecin analogue, in aqueous solutions containing β-cyclodextrin sulfobutyl ether (SBE-CD) or other solubilizing agents. The formulations manufactured by this method are more simple and cost-effective, of higher doses and better quality in terms of manufacture loss and formulation stability, and can be free of organic solvents (e.g., DMSO or N-methyl-2-pyrrolidinone).
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
10/216,883
Filing Date
08/12/2002
Recommended Citation
Xiang, Tiang-Xiang and Anderson, Bradley D., "Pharmaceutical Formulation for Poorly Water Soluble Camptothecin Analogues" (2003). Pharmaceutical Sciences Faculty Patents. 78.
https://uknowledge.uky.edu/ps_patents/78
